High-flow nasal cannula use for respiratory support in children for indications other than acute bronchiolitis

Area of Science:

• Pediatric critical care medicine
• Respiratory medicine
• Evidence-based medicine

Background:

• High-flow nasal cannula (HFNC) is increasingly used for respiratory support in children.
• Evidence regarding its benefits and harms in specific pediatric populations is still developing.
• Acute bronchiolitis is a common indication, but HFNC use extends to other respiratory conditions.

Purpose of the Study:

• To systematically review the evidence on the benefits and harms of HFNC.
• To compare HFNC with conventional oxygen therapy or non-invasive ventilation.
• To focus on pediatric respiratory support for indications other than acute bronchiolitis.

Main Methods:

• Cochrane systematic review methodology.
• Inclusion of randomized controlled trials and other relevant study designs.
• Assessment of benefits (e.g., reduced need for mechanical ventilation, shorter hospital stay) and harms (e.g., adverse events).

Main Results:

• This section will be populated once the review is completed.
• Anticipated results will detail comparative effectiveness and safety profiles.
• Results will guide clinical decision-making for HFNC use.

Conclusions:

• This section will be populated once the review is completed.
• Conclusions will summarize the overall evidence for HFNC in pediatric respiratory support.
• Recommendations for clinical practice and future research will be provided.